GIFOF vs GIKLY
To understand the difference between Grifols SA - Ordinary Shares - Class B (Non-Voting) (GIFOF) vs. Grifols SA - ADR (GIKLY) it is enough to know the definitions of Ordinary Shares - Class B and ADR
Ordinary Shares - Class B - Generally, Class B shares are issued by a company as a common stock with fewer voting rights and lower dividend priority than Class A shares. Class B may also have lower repayment priority in the event of a bankruptcy.
ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GIFOF’s FA Score shows that 1 FA rating(s) are green whileGIKLY’s FA Score has 1 green FA rating(s).
- GIFOF’s FA Score: 1 green, 4 red.
- GIKLY’s FA Score: 1 green, 4 red.
Price Growth
GIFOF (@Pharmaceuticals: Major) experienced а -2.78% price change this week, while GIKLY (@Pharmaceuticals: Major) price change was -9.49% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.
Reported Earning Dates
GIKLY is expected to report earnings on Feb 27, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (-0.02% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
| GIFOF | GIKLY | GIFOF / GIKLY | |
| Capitalization | 8.79B | 8.79B | 100% |
| EBITDA | 726M | 726M | 100% |
| Gain YTD | -15.271 | -41.223 | 37% |
| P/E Ratio | 48.31 | 75.19 | 64% |
| Revenue | 6.46B | 6.46B | 100% |
| Total Cash | 557M | 557M | 100% |
| Total Debt | 10.9B | 10.9B | 100% |
GIFOF | GIKLY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 86 | 86 | |
PRICE GROWTH RATING 1..100 | 56 | 59 | |
P/E GROWTH RATING 1..100 | 94 | 97 | |
SEASONALITY SCORE 1..100 | 38 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GIFOF's Valuation (3) in the null industry is in the same range as GIKLY (17). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.
GIFOF's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.
GIFOF's SMR Rating (86) in the null industry is in the same range as GIKLY (86). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.
GIFOF's Price Growth Rating (56) in the null industry is in the same range as GIKLY (59). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.
GIFOF's P/E Growth Rating (94) in the null industry is in the same range as GIKLY (97). This means that GIFOF’s stock grew similarly to GIKLY’s over the last 12 months.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
GIFOF and
Correlation & Price change
A.I.dvisor indicates that over the last year, GIFOF has been loosely correlated with GRFS. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GIFOF jumps, then GRFS could also see price increases.
| Ticker / NAME | Correlation To GIFOF | 1D Price Change % | ||
|---|---|---|---|---|
| GIFOF | 100% | +0.38% | ||
| GRFS - GIFOF | 37% Loosely correlated | +1.18% | ||
| GIFLF - GIFOF | 30% Poorly correlated | N/A | ||
| GIKLY - GIFOF | 27% Poorly correlated | N/A | ||
| AMRN - GIFOF | 21% Poorly correlated | -1.74% | ||
| BAYZF - GIFOF | 12% Poorly correlated | -1.49% | ||
More | ||||
GIKLY and
Correlation & Price change
A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.
| Ticker / NAME | Correlation To GIKLY | 1D Price Change % | ||
|---|---|---|---|---|
| GIKLY | 100% | N/A | ||
| GRFS - GIKLY | 69% Closely correlated | +1.18% | ||
| GIFOF - GIKLY | 27% Poorly correlated | +0.38% | ||
| GIFLF - GIKLY | 25% Poorly correlated | N/A | ||
| ORINY - GIKLY | 9% Poorly correlated | -1.85% | ||
| OPHLY - GIKLY | 9% Poorly correlated | +1.61% | ||
More | ||||